Baker Hughes Co vs Illumina, Inc. — how do they compare? Baker Hughes Co trades at $64.74 (market cap $64.34B), while Illumina, Inc. trades at $193.06 (market cap $29.12B). The key difference: Baker Hughes Co is far larger — about 2.2× Illumina, Inc.'s market cap, and Baker Hughes Co pays a 1.42% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| BKR | ILMN | |
|---|---|---|
Market Cap | $64.34B | $29.12B |
Sector | Energy | Health |
52-Week High | $69.67 | $205.10 |
52-Week Low | $42.51 | $91.00 |
Enterprise Value | $64.86B | $30.48B |
Dividend Yield | 1.42% | — |
Trailing returns across standard periods
Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.
Read more on BKR →Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →